8,61,000 Equity Shares allotted pursuant to conversion of warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd has allotted 8,61,000 equity shares (face value ₹10 each) to 6 non-promoter investors upon conversion of their previously issued convertible warrants. The conversion was done at ₹42.25 per share, of which the remaining 75% (₹31.6875 per share) was received as the balance exercise price, bringing in approximately ₹2.73 crore to the company. As a result, the company's paid-up equity capital has increased from ₹14.00 crore (1.40 crore shares) to ₹14.86 crore (1.49 crore shares). The newly issued shares will rank equally with existing shares, and the company will apply for listing and trading approval from BSE.
This is a routine warrant conversion that increases the share count by about 6.1% (dilution) and adds cash to the company, but since it was pre-disclosed in August 2025, the market impact should already be factored in. Shareholders should note a modest increase in outstanding shares.